‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Speaking of SurgOnc
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma
30
00:00:00
/ 00:12:51
30